Clinical pathway (CP) is a quality and cost control instrument in hospitals designed to ensure service standardization, efficiency of Length of Stay (LOS), and control of healthcare costs. Dengue Haemorrhagic Fever (DHF) in children is an infectious disease that often requires hospitalization, with considerable variation in LOS and treatment costs. This study aimed to assess the effectiveness of CP implementation on LOS and cost of care among pediatric DHF patients at Rumah Sakit Islam Nahdlatul Ulama (RSI NU) Demak. This research applied a quantitative approach using a retrospective descriptive-analytic design. Data were obtained from medical records of 34 pediatric DHF patients hospitalized at RSI NU Demak between January and June 2025. The variables analyzed included LOS and cost of care based on care class. Descriptive analysis was conducted using mean, standard deviation (SD), and the difference between actual costs of care and INA-CBGs tariffs. The results showed that the average LOS for pediatric DHF patients was 4.56 ± 1.07 days, ranging from 2 to 7 days, lower than the CP standard of 5 days. By care class, the mean LOS was 6 days for class I, 4.54 ± 1.15 days for class II, and 4.45 ± 1.01 days for class III. Regarding care costs, the mean cost difference was -IDR 1,605,429 for class I, -IDR 642,372 ± 476,993 for class II, and -IDR 555,046 ± 481,767 for class III. Negative values indicate that the actual hospital costs are higher than the INA-CBGs tariff (deficit). Descriptively, the LOS stay among pediatric DHF patients was lower than the CP standard; however, cost variations were still observed.
Copyrights © 2026